Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy VRTX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Vertex Pharmaceuticals (VRTX)

@ 4:00 PM
Click the portfolio to add VRTX:
Close [X]
+ Add VRTX to Portfolio
  
  Last Trade: $37.04 +0.26 (0.71%)
  Volume: 3,250,110 97% of avg daily volume
       
  Avg Volume: 3,358,704
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 35.98 - 37.23
  Open: 37.13
  Previous Close: 36.78
  52-wk Range: 26.50 - 58.87
  Market Cap: 7.8B
  P/E: 459.8
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (-0.7%)
Cancer Stocks (-0.9%)
Spy VRTX

? Pro holders
? Member holders
? Items submitted
Additional VRTX resources



Customize Links
To see which Pros and tickerspy members own VRTX Sign up now
Latest VRTX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Top Earnings Previews For Thursday
DOW  IP  K  MRK  HOT  YRCW  PHM  TRMB  VRTX  GILD  RCL  BZH  MA  CME  GNW  BX  
Linked by 24/7 Wall St. - February 01, 03:43PM from (247wallst.com)
Earnings season is still upon us. There are going to be many big earnings reports Thursday and we would consider Thursday  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
F.D.A. Approves Cystic Fibrosis Drug
VRTX  
Linked by NYTimes - January 31, 01:25PM from (feeds.nytimes.com)
The federal agency called it a “breakthrough therapy” because current therapies treat only the symptoms of the genetic  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vertex Falls as Analyst Cuts Sales Estimates on Hepatitis C Pill
MRK  VRTX  
Linked by Bloomberg - January 30, 11:00AM from (www.bloomberg.com)
Vertex Pharmaceuticals Inc. (VRTX) fell the most in two months after an analyst with Leerink Swann & Co. cut sales  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Long-Term Play In Lab Work
PFE  JNJ  PRXL  VRTX  ICLR  CRL  MORN  WX  BBH  
Linked by Investopedia Stock Analysis - January 16, 03:17PM from (stocks.investopedia.com)
As drugmakers beef up their pipelines in this world of rising costs, the contract research sector should profit.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Bristol-Myers Pays Up To Patch A Gap
BMY  JNJ  VRTX  GILD  ACHN  IDIX  INHX  
Linked by Investopedia Stock Analysis - January 09, 04:35PM from (stocks.investopedia.com)
Bristol-Myers recently bought Inhibitex, a company leading the way in developing a treatment for Hepatitis C.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tracking Dividends in Biotech: Who Follows Amgen in Payouts?
PFE  MRK  AMGN  CELG  REGN  BIIB  VRTX  PDLI  ALXN  CBST  [VRUS]  
Linked by 24/7 Wall St. - January 04, 08:01AM from (247wallst.com)
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
2 Amgen Executives To Retire
ABT  AMGN  VRTX  MS  
Linked by NYTimes - December 15, 09:58PM from (feeds.nytimes.com)
Kevin W. Sharer, the chief executive, and Dr. Roger M. Perlmutter, the head of research, will step down in 2012. The company’s  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Is Third Time The Charm For Gilead?
BMY  JNJ  MRK  VRTX  GILD  ACHN  GSK  INHX  [VRUS]  
Linked by Investopedia Stock Analysis - November 22, 01:23PM from (stocks.investopedia.com)
Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
GILD Acquires VRUS
VRTX  GILD  ACHN  IDIX  INHX  [VRUS]  
Linked by Benzinga.com - November 21, 11:00AM from (www.benzinga.com)
Gilead Sciences (NASDAQ: GILD) announced a blockbuster move on Monday with its planned $11 billion cash acquisition of Pharmassett  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Top Analyst Calls of the Week
CSC  PIR  AAPL  HD  YRCW  TEVA  CSCO  VRTX  ALU  GMCR  SRDX  DF  AMZN  EPD  CXW  ALIM  GNW  MPEL  GRPN  
Linked by 24/7 Wall St. - November 12, 09:19AM from (247wallst.com)
Each morning 24/7 Wall St. issues a summary list of key analyst upgrades, downgrades, and initiations issued by Wall Street  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 18



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource